151 related articles for article (PubMed ID: 26573846)
1. Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial.
Kaapu KJ; Murtola TJ; Määttänen L; Talala K; Taari K; Tammela TL; Auvinen A
Cancer Causes Control; 2016 Feb; 27(2):157-64. PubMed ID: 26573846
[TBL] [Abstract][Full Text] [Related]
2. Sotalol, but not digoxin is associated with decreased prostate cancer risk: A population-based case-control study.
Kaapu KJ; Ahti J; Tammela TL; Auvinen A; Murtola TJ
Int J Cancer; 2015 Sep; 137(5):1187-95. PubMed ID: 25656312
[TBL] [Abstract][Full Text] [Related]
3. Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men.
Kaapu KJ; Rantaniemi L; Talala K; Taari K; Tammela TLJ; Auvinen A; Murtola TJ
Sci Rep; 2018 Jul; 8(1):10308. PubMed ID: 29985440
[TBL] [Abstract][Full Text] [Related]
4. Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer.
Kaapu KJ; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
Br J Cancer; 2016 Nov; 115(11):1289-1295. PubMed ID: 27755533
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic drug usage and prostate cancer: a population-based cohort study.
Kao LT; Huang CC; Lin HC; Huang CY
Asian J Androl; 2018; 20(1):37-42. PubMed ID: 28857052
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
[TBL] [Abstract][Full Text] [Related]
7. Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.
Murtola TJ; Peltomaa AI; Talala K; Määttänen L; Taari K; Tammela TLJ; Auvinen A
Eur Urol Focus; 2017 Apr; 3(2-3):212-220. PubMed ID: 28753762
[TBL] [Abstract][Full Text] [Related]
8. 5-Alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial.
Murtola TJ; Karppa EK; Taari K; Talala K; Tammela TL; Auvinen A
Int J Cancer; 2016 Jun; 138(12):2820-8. PubMed ID: 26804670
[TBL] [Abstract][Full Text] [Related]
9. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
Ho AT; Pai SM; Timothy P; Pai RG
Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive drugs and prostate cancer risk in a Finnish population-based cohort.
Siltari A; Murtola TJ; Talala K; Taari K; Tammela TLJ; Auvinen A
Scand J Urol; 2018; 52(5-6):321-327. PubMed ID: 30698056
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Prostate-specific Antigen-based Prostate Cancer Screening Among Men Using Nonsteroidal Anti-inflammatory Drugs.
Murtola TJ; Vettenranta AM; Talala K; Taari K; Stenman UH; Tammela TLJ; Auvinen A
Eur Urol Focus; 2018 Dec; 4(6):851-857. PubMed ID: 28753870
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.
Murtola TJ; Tammela TL; Määttänen L; Huhtala H; Platz EA; Ala-Opas M; Stenman UH; Auvinen A
Int J Cancer; 2010 Oct; 127(7):1650-9. PubMed ID: 20073066
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
Luedtke SA; Kuhn RJ; McCaffrey FM
Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
[TBL] [Abstract][Full Text] [Related]
14. Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial.
Veitonmäki T; Murtola TJ; Talala K; Taari K; Tammela T; Auvinen A
PLoS One; 2016; 11(4):e0153413. PubMed ID: 27100876
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial.
Murtola TJ; Tammela TL; Määttänen L; Ala-Opas M; Stenman UH; Auvinen A
Br J Cancer; 2009 Sep; 101(5):843-8. PubMed ID: 19654575
[TBL] [Abstract][Full Text] [Related]
16. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
Jaeggi ET; Carvalho JS; De Groot E; Api O; Clur SA; Rammeloo L; McCrindle BW; Ryan G; Manlhiot C; Blom NA
Circulation; 2011 Oct; 124(16):1747-54. PubMed ID: 21931080
[TBL] [Abstract][Full Text] [Related]
17. A cohort study of digoxin exposure and mortality in men with prostate cancer.
Flahavan EM; Sharp L; Bennett K; Barron TI
BJU Int; 2014 Feb; 113(2):236-45. PubMed ID: 23937513
[TBL] [Abstract][Full Text] [Related]
18. Digoxin use after diagnosis of prostate cancer and survival: a population-based cohort study.
Karasneh RA; Murray LJ; Hughes CM; Cardwell CR
Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1099-103. PubMed ID: 27146482
[TBL] [Abstract][Full Text] [Related]
19. Warfarin use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
Kinnunen PT; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
Scand J Urol; 2016 Dec; 50(6):413-419. PubMed ID: 27628763
[TBL] [Abstract][Full Text] [Related]
20. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA
Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
